Lori Hartwell

Last updated
Lori Hartwell
LoriHartwell 2005.jpg
Hartwell in 2005
Born1966
NationalityAmerican
OccupationPresident of the Renal Support Network
Known forFounder of the Renal Support Network and author of "Chronically Happy: Joyful Living in Spite of Chronic Illness"

Lori Hartwell (born 1966) is the Founder and President of the Renal Support Network, author of Chronically Happy: Joyful Living in Spite of Chronic Illness, and co-host of KidneyTalk, a biweekly webcast of issues of interest to those with Chronic Kidney Disease (CKD).

Contents

CKD history

Diagnosed with CKD at the age of 2 in 1968, [1] Hartwell has had 12 years of dialysis and four transplants. [2]

Renal Support Network

Hartwell founded the Renal Support Network (RSN) in 1993 as an American nonprofit, kidney patient-focused, kidney patient-run organization to benefit individuals affected by CKD. Hartwell began an annual Renal Teen Prom in 1999. As of 2008 nine Renal teen Proms have been held in Los Angeles and one in Washington DC. [3]

KidneyTalk

Hartwell co-hosts a bi-weekly webcast called "KidneyTalk" with Stephen Furst. The shows run about 30 minutes covering topics of interest to those with CKD. KidneyTalk's first show was on June 6, 2006.

Awards

Publications

Hartwell has contributed to several educational and scientific publications including in peer-reviewed journals. [4] [5]

Bibliography

Related Research Articles

<span class="mw-page-title-main">Nephrology</span> Medical study concerned with the kidneys

Nephrology is a specialty of adult internal medicine and pediatric medicine that concerns the study of the kidneys, specifically normal kidney function and kidney disease, the preservation of kidney health, and the treatment of kidney disease, from diet and medication to renal replacement therapy. The word “renal” is an adjective meaning “relating to the kidneys”, and its roots are French or late Latin. Whereas according to some opinions, "renal" and "nephro" should be replaced with "kidney" in scientific writings such as "kidney medicine" or "kidney replacement therapy", other experts have advocated preserving the use of renal and nephro as appropriate including in "nephrology" and "renal replacement therapy", respectively.

<span class="mw-page-title-main">Kidney dialysis</span> Removal of nitrogenous waste and toxins from the body in place of or to augment the kidney

Kidney dialysis is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. This is referred to as renal replacement therapy. The first successful dialysis was performed in 1943.

<span class="mw-page-title-main">Kidney failure</span> Disease where the kidneys fail to adequately filter waste products from the blood

Kidney failure, also known as end-stage kidney disease, is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels. Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible. Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion. Complications of acute and chronic failure include uremia, hyperkalaemia, and volume overload. Complications of chronic failure also include heart disease, high blood pressure, and anaemia.

<span class="mw-page-title-main">Assessment of kidney function</span> Ways of assessing the function of the kidneys

Assessment of kidney function occurs in different ways, using the presence of symptoms and signs, as well as measurements using urine tests, blood tests, and medical imaging.

<span class="mw-page-title-main">Kidney disease</span> Damage to or disease of a kidney

Kidney disease, or renal disease, technically referred to as nephropathy, is damage to or disease of a kidney. Nephritis is an inflammatory kidney disease and has several types according to the location of the inflammation. Inflammation can be diagnosed by blood tests. Nephrosis is non-inflammatory kidney disease. Nephritis and nephrosis can give rise to nephritic syndrome and nephrotic syndrome respectively. Kidney disease usually causes a loss of kidney function to some degree and can result in kidney failure, the complete loss of kidney function. Kidney failure is known as the end-stage of kidney disease, where dialysis or a kidney transplant is the only treatment option.

<span class="mw-page-title-main">Chronic kidney disease</span> Medical condition

Chronic kidney disease (CKD) is a type of kidney disease in which a gradual loss of kidney function occurs over a period of months to years. Initially generally no symptoms are seen, but later symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion. Complications can relate to hormonal dysfunction of the kidneys and include high blood pressure, bone disease, and anemia. Additionally CKD patients have markedly increased cardiovascular complications with increased risks of death and hospitalization.

<span class="mw-page-title-main">Metabolic acidosis</span> Medical condition

Metabolic acidosis is a serious electrolyte disorder characterized by an imbalance in the body's acid-base balance. Metabolic acidosis has three main root causes: increased acid production, loss of bicarbonate, and a reduced ability of the kidneys to excrete excess acids. Metabolic acidosis can lead to acidemia, which is defined as arterial blood pH that is lower than 7.35. Acidemia and acidosis are not mutually exclusive – pH and hydrogen ion concentrations also depend on the coexistence of other acid-base disorders; therefore, pH levels in people with metabolic acidosis can range from low to high.

<span class="mw-page-title-main">Home hemodialysis</span>

Home hemodialysis (HHD) is the provision of hemodialysis to purify the blood of a person whose kidneys are not working normally, in their own home. One advantage to doing dialysis at home is that it can be done more frequently and slowly, which reduces the "washed out" feeling and other symptoms caused by rapid ultrafiltration, and it can often be done at night, while the person is sleeping.

Renal osteodystrophy/adynamic bone disease is currently defined as an alteration of bone morphology in patients with chronic kidney disease (CKD). It is one measure of the skeletal component of the systemic disorder of chronic kidney disease-mineral and bone disorder (CKD-MBD). The term "renal osteodystrophy" was coined in 1943, 60 years after an association was identified between bone disease and kidney failure.

<span class="mw-page-title-main">Interstitial nephritis</span> Medical condition

Interstitial nephritis, also known as tubulointerstitial nephritis, is inflammation of the area of the kidney known as the renal interstitium, which consists of a collection of cells, extracellular matrix, and fluid surrounding the renal tubules. It is also known as intestinal nephritis because clinical picture is showing mesenteric lymphadenitis in such cases of acute pyelonephritis. More specifically in case of recurrent urinary tract infection secondary infection can spread to adjacent intestine. In addition to providing a scaffolding support for the tubular architecture, the interstitium has been shown to participate in the fluid and electrolyte exchange as well as endocrine functions of the kidney.

<span class="mw-page-title-main">Dialysis disequilibrium syndrome</span> Complication of dialysis

Dialysis disequilibrium syndrome (DDS) is the collection of neurological signs and symptoms, attributed to cerebral edema, during or following shortly after intermittent hemodialysis or CRRT.

<span class="mw-page-title-main">Robert Provenzano</span> American physician

Robert Provenzano is an American nephrologist. He is also an Associate Clinical Professor of Medicine at Wayne State University School of Medicine.

The Renal Support Network (RSN) is an American nonprofit, kidney patient-focused, kidney patient-run organization that works to benefit individuals affected by chronic kidney disease (CKD). RSN's mission is to help patients develop their personal coping skills, talents, and employability by educating and empowering them to take control of the course and management of the disease.

Nathan W. Levin is an American physician and founder of the Renal Research Institute, LLC., a research institute dedicated to improving the outcomes of patients with kidney disease, particularly those requiring dialysis. Levin is one of the most prominent and renowned figures in clinical nephrology as well as nephrology research. He has authored multiple book chapters and over 350 peer-reviewed publications, including articles in leading journals such as Nature, the New England Journal of Medicine, and The Lancet.

<span class="mw-page-title-main">Carmine Zoccali</span>

Carmine Zoccali is an Italian nephrologist and a clinical investigator. He has contributed to research in several fields, most notably hypertension and cardiovascular complications in chronic kidney disease (CKD), CKD progression and clinical epidemiology of kidney diseases at large. He is known for his studies on cardiovascular risk in CKD and dialysis patients. He was among the earliest investigators that focused on the relevance of endothelial dysfunction and inflammation for the high risk of cardiovascular disease in these populations. In this research area, he was the first to link endogenous inhibitors of the nitric oxide system with death and cardiovascular disease. and the first to document a relationship between sympathetic over-activity and these outcomes Dr Zoccali is a practicing specialist in Nephrology, with a national qualification for the full professorship in Nephrology. He is also a specialist in hypertension, certified by the European Society of Hypertension (ESH).

Onconephrology is a specialty in nephrology that deals with the study of kidney diseases in cancer patients. A nephrologist who takes care of patients with cancer and kidney disease is called an onconephrologist. This branch of nephrology encompasses nephrotoxicity associated with existing and novel chemotherapeutics, kidney disease as it pertains to stem cell transplant, paraneoplastic kidney disorders, paraproteinemias, electrolyte disorders associated with cancer, and more as discussed below.

Sucroferric oxyhydroxide, sold under the brand name Velphoro, is a non-calcium, iron-based phosphate binder used for the control of serum phosphorus levels in adults with chronic kidney disease (CKD) on haemodialysis (HD) or peritoneal dialysis (PD). It is used in form of chewable tablets.

Sree Bhushan Raju M.D., D.M., Diplomate of National Board, is a nephrologist from Telangana, India. He is currently professor and head, Dept of Nephrology, Nizam's Institute of Medical Sciences Panjagutta, Hyderabad. Which is one of the largest teaching Department in India having eight DM seats. He is one of the principal investigators of CKD task force by Indian Council of Medical Research (ICMR) to evaluate the prevalence of CKD in adult urban population in India.

Chronic kidney disease–mineral and bone disorder (CKD-MBD) is one of the many complications associated with chronic kidney disease. It represents a systemic disorder of mineral and bone metabolism due to CKD manifested by either one or a combination of the following:

A renal diet is a diet aimed at keeping levels of fluids, electrolytes, and minerals balanced in the body in individuals with chronic kidney disease or who are on dialysis. Dietary changes may include the restriction of fluid intake, protein, and electrolytes including sodium, phosphorus, and potassium. Calories may also be supplemented if the individual is losing weight undesirably.

References

  1. "RSN Speakers » Lori Hartwell". Renal Support Network. Archived from the original on May 3, 2016. Retrieved January 26, 2015.
  2. 1 2 "State Senator Jack Scott Announces 'Woman of the Year'". dist21.casen.govoffice.com. March 2005. Archived from the original on 2011-08-14.
  3. Doyle, Alicia (January 28, 2008). "For one night, their kidney disease problems get left behind: A dance to remember". Ventura County Star. Archived from the original on May 24, 2008.
  4. Kalantar-Zadeh, Kamyar; McCullough, Peter A.; Agarwal, Sanjay Kumar; Beddhu, Srinivasan; Boaz, Mona; Bruchfeld, Annette; Chauveau, Philippe; Chen, Jing; De Sequera, Patricia; Gedney, Nieltje; Golper, Thomas A.; Gupta, Malini; Harris, Tess; Hartwell, Lori; Liakopoulos, Vassilios; Kopple, Joel D.; Kovesdy, Csaba P.; MacDougall, Iain C.; Mann, Johannes F. E.; Molony, Donald; Norris, Keith C.; Perlmutter, Jeffrey; Rhee, Connie M.; Riella, Leonardo V.; Weisbord, Steven D.; Zoccali, Carmine; Goldsmith, David (Mar 13, 2021). "Nomenclature in nephrology: preserving 'renal' and 'nephro' in the glossary of kidney health and disease". J. Nephrol. 34 (3): 639–648. doi:10.1007/s40620-021-01011-3. PMC   8192439 . PMID   33713333.
  5. Hartwell L (Dec 6, 2019). "Public Policy and Patient Choice of Dialysis Modality". Clin J Am Soc Nephrol. 14 (12): 1677–1678. doi:10.2215/CJN.12151019. PMC   6895479 . PMID   31811083.